Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 4/20 | 0.51 |
| ▸ | CNR2 | P34972 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | KLF10 | Q13118 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29547368 | 0.91 | ESR1 (0.59) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL745012 | 0.91 | ESR1 (0.59) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL29377969 | 0.90 | ALDH1A1 (0.61) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL122974 | 0.90 | ALDH1A1 (0.61) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL29352462 | 0.90 | ALDH1A1 (0.61) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| Bisphenol A SCHEMBL7744724 | 0.87 | ALDH1A1 (0.64) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL9617582 | 0.87 | ALDH1A1 (0.64) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL29515859 | 0.87 | ALDH1A1 (0.64) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL7917289 | 0.87 | ALDH1A1 (0.53) | ESR1ALDH1A1ESR2CYP3A4ALOX15 | |
| SCHEMBL18635220 | 0.86 | ESR1 (0.69) | ESR1ALDH1A1ESR2CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6063843-A | MOLDED ARTICLES, FIBERS; PHOTOSTABILITY, HEAT AND OXIDATION RESISTANCE | CLARIANT FINANCE (BVI) LIMITED (VG) | 2000-05-16 | — | — | US | claimed |
| EP-0344550-B1 | Method for stabilizing polymer materials, stabilizer composition therefor and stabilized polymer materials | VUCHT AS (SK) | 1993-12-08 | — | — | EP | claimed |
| EP-0344550-A1 | Method for stabilizing polymer materials, stabilizer composition therefor and stabilized polymer materials | Vucht a.s. Bratislava (SK) | 1989-12-06 | — | — | EP | claimed |
| US-9249090-B2 | N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-9249090-B2 | N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20150038742-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-02-05 | — | — | US | disclosed |
| US-20150038742-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-02-05 | — | — | US | disclosed |
| US-6365634-B1 | CUMYLPHENOL; NONSTEROIDAL ANTIINFLAMMATORY AGENT; FROM PEAT BOG | C-P TECHNOLOGY LIMITED PARTNERSHIP | 2002-04-02 | — | — | US | disclosed |
| EP-0697425-B1 | Hardener blend for epoxy resins | CIBA GEIGY AG (CH) | 1999-03-17 | — | — | EP | disclosed |
| US-5821318-A | POLYAMINES; ALCOHOL VISCOSITY DEPRESSANT; PHENOLIC ACCELERATOR | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-10-13 | — | — | US | disclosed |
| EP-0697425-A1 | Hardener blend for epoxy resins | CIBA-GEIGY AG (CH) | 1996-02-21 | — | — | EP | disclosed |
| EP-0344550-B1 | Method for stabilizing polymer materials, stabilizer composition therefor and stabilized polymer materials | VUCHT AS (SK) | 1993-12-08 | — | — | EP | disclosed |
| EP-0344550-A1 | Method for stabilizing polymer materials, stabilizer composition therefor and stabilized polymer materials | Vucht a.s. Bratislava (SK) | 1989-12-06 | — | — | EP | disclosed |
| EP-0344550-A1 | Method for stabilizing polymer materials, stabilizer composition therefor and stabilized polymer materials | Vucht a.s. Bratislava (SK) | 1989-12-06 | — | — | EP | disclosed |
| US-4439570-A | BUTADIENE RUBBERS, THIORGANO PHOSPHINE | EUTECO IMPIANTI S.P.A. (IT) | 1984-03-27 | — | — | US | disclosed |
| US-3933928-A | Method for producing 2,6-di-tert.-butyl-4-cumyl phenol | MITSUI TOATSU CHEMICALS, INCORPORATED (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038742-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | ESR1 623/4885ALDH1A1 574/4885ESR2 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.